Miscellaneous Agents

Panic Away

Panic Away Handbook

Get Instant Access

Buspirone, an anxiolytic with partial 5-HT agonism and low sedative potential, has not been evaluated in a controlled manner for the management of anxiety in PD. However, in a 12-week randomized, controlled study (n = 16) evaluating the effect of buspirone on PD motor symptoms, moderate doses (10-40 mg/d) of buspirone were associated with a modest beneficial effect on anxiety (41). Higher daily doses (i.e., 100 mg) of buspirone significantly enhanced anxiety and worsened parkinsonism. In a three-week randomized, controlled study (n = 10) evaluating the effect of low-dose buspirone on levodopa-induced dyskinesia, no significant effect on anxiety was noted (62). However, since the therapeutic onset of buspirone requires up to six weeks, the short duration of this study may not have been sufficient to detect any significant anxiolytic effect.

Was this article helpful?

0 0
Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook


Post a comment